Diabetes Management Meds
At Wolter Pharmaceuticals Pvt. Ltd., we understand the importance of comprehensive diabetes care. Our Diabetes Management Range is designed to provide effective blood sugar control through well-researched, synergistic combinations that enhance treatment outcomes and patient compliance.
WOLMETT TRIO 1 (Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg)
A balanced formulation ideal for patients requiring mild to moderate glycemic control. It combines insulin secretion stimulation, insulin sensitivity improvement, and glucose utilization enhancement to ensure effective diabetes management.
WOLMETT TRIO 2 (Glimepiride 2mg + Metformin 500mg + Pioglitazone 15mg)
Designed for patients with higher glycemic needs, this formulation provides stronger control over blood sugar while maintaining safety and tolerability. It is particularly effective in reducing insulin resistance and improving overall metabolic balance.
Together, WOLMETT TRIO 1 and 2 strengthen Wolter’s commitment to providing comprehensive diabetes care solutions, ensuring physicians have reliable tools to improve patient outcomes and quality of life.
